<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03352648</url>
  </required_header>
  <id_info>
    <org_study_id>R659/17-CCM698</org_study_id>
    <nct_id>NCT03352648</nct_id>
  </id_info>
  <brief_title>CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DebrillAtor ThErapy: an International Registry (DERIVATE)</brief_title>
  <acronym>DERIVATE</acronym>
  <official_title>CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DebrillAtor ThErapy: an International Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GIANLUCA PONTONE</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centro Cardiologico Monzino</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The DERIVATE study was conceived to integrate the information resulted from clinical data,
      transthoracic echocardiography, and cardiac magnetic resonance (CMR) imaging to provide a
      more reliable risk stratification in patients affected by heart failure (HF) and worthy of
      prophylactic implanted cardioverter defibrillator (ICD) therapy. The main purposes of this
      multicenter registry are to: 1) determine CMR findings, and specifically late gadolinium
      enhancement (LGE) features, T1 mapping, and extracellular volume (ECV) that predict sudden
      cardiac death (SCD) and ventricular arrhythmia; 2) provide a comprehensive clinical and
      imaging score that effectively improves the selection of patients who deserve a prophylactic
      ICD therapy; 3) evaluate the contribution of machine learning to predict major adverse
      cardiac events (MACE) as compared to standard clinical scores.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current guidelines provide indications for primary prevention implanted cardioverter
      defibrillator (ICD) therapy based on left ventricle ejection fraction (LVEF) and New York
      Heart Association (NYHA) class. This strategy is able to intercept only part of fatal
      arrhythmic events and, on the other hand, led to useless ICD implantations mainly among those
      patients with severe heart failure (HF) who will never incur in sever arrhythmias but rather
      will die because of decompensated HF. Cardiac magnetic resonance offers the possibility of
      identifying and quantitatively assessing myocardium fibrosis both localized in a specific
      area and diffuse and has already proved a significant prognostic meaning. DERIVATE is a
      prospective, international, multicenter, observational registry of stable HF patients with
      reduced LVEF who underwent clinical evaluation, transthoracic echocardiography (TTE) and
      cardiac magnetic resonance (CMR). Specifically, the primary aim of DERIVATE is to determine
      CMR findings that predict outcomes, with incremental value over LVEF and NYHA classification.

      The DERIVATE registry uses a collaborative design with contribution and merger of similar
      prospectively enrolled cohorts from 33 sites in 6 countries in Europe and North America. The
      targeted population for the DERIVATE registry is a large sample of patients with clinical
      history of chronic HF who have undergone CMR by referral physician. Indication for CMR exams
      was recorded and classified according to the known causes of HF. All DERIVATE study patients
      are followed for all-cause mortality, sudden cardiac death (SCD), cardiovascular death
      (including death caused by acute myocardial infarction and stroke), sustained ventricular
      tachycardia (VT), aborted SCD, hospitalization or cardiac death related to chronic HF. The
      follow up minimum period is 12 months. Complete risk factors, clinical presentation,
      echocardiography and CMR data recording, and follow-up for all-outcomes will contribute data
      for common analysis.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">January 2010</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>all-cause mortality</measure>
    <time_frame>The follow up minimum period is 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>sudden cardiac death (SCD)</measure>
    <time_frame>The follow up minimum period is 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>aborted sudden cardiac death (SCD)</measure>
    <time_frame>The follow up minimum period is 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart failure (HF) death</measure>
    <time_frame>The follow up minimum period is 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sustained ventricular tachycardia (VT)</measure>
    <time_frame>The follow up minimum period is 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>major adverse cardiac events (MACE)</measure>
    <time_frame>The follow up minimum period is 12 months</time_frame>
    <description>composite end point of SCD, aborted SCD, cardiovascular death, and sustained VT</description>
  </secondary_outcome>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Heart Failure</condition>
  <condition>Left Ventricular Systolic Dysfunction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consist of patients at multiple international centers undergoing
        clinically-indicated cardiac magnetic resonance (CMR) as part of their standard of care.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Heart Failure patients (according to the ACC/AHA classification) with known ischemic
             cardiomyopathy (ICM) or non ischemic dilated cardiomyopathy (DCM)

          -  reduced left ventricle ejection fraction (LVEF) (&lt;55%)

        Exclusion Criteria:

          -  pregnancy

          -  current alcohol or drug abuse

          -  unstable angina

          -  decompensated HF (NYHA class IV) in the previous 1 month

          -  acute myocarditis in the previous 3 months

          -  recent myocardial infarction (MI) (&lt;40 days) or)

          -  severe valvular disease

          -  cardiac amyloidosis

          -  hypertrophic cardiomyopathy

          -  arrhthmogenic right ventricular cardiomyopathy

          -  takotsubo cardiomyopathy

          -  congenital heart disease

          -  non CMR compatible device

          -  estimated glomerular filtration rate â‰¤30 mL/min/1.73m2

          -  other contraindication to gadolinium contrast agent

          -  severe claustrophobia

          -  participating in other trials with an active treatment arm (not to exclude patients
             who are in trials of diagnostic techniques or approved therapies)

          -  unwilling or unable to provide informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gianluca Pontone, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS Centro Cardiologico Monzino, Milano, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrea Igoren Guaricci, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Policlinico Consorziale of Bari, Bari , Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jurg Schwitter, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lausanne University Hospital-CHUV, Lausanne, Vaud, Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pier Giorgio Masci, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lausanne University Hospital-CHUV, Lausanne, Vaud, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Loyola University of Chicago,</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29402</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KU Leuven-University of Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St.Luke's Hospital Thessaloniki</name>
      <address>
        <city>ThessalonÃ­ki</city>
        <zip>57010</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Medico-Chirurgico Accreditato Villa dei Fiori</name>
      <address>
        <city>Acerra</city>
        <zip>80121</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Policlinico Consorziale</name>
      <address>
        <city>Bari</city>
        <zip>70122</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Papa Giovanni XXIII</name>
      <address>
        <city>Bergamo</city>
        <zip>24121</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O. Desio e Vimercate - P.O. Desio</name>
      <address>
        <city>Desio</city>
        <zip>20033</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedali Riuniti University Hospital</name>
      <address>
        <city>Foggia</city>
        <zip>71100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Messina</name>
      <address>
        <city>Messina</city>
        <zip>98121</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Policlinico San Donato,</name>
      <address>
        <city>Milano</city>
        <zip>20097</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vita-Salute San Raffaele University</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Cardiologico Monzino, IRCCS</name>
      <address>
        <city>Milano</city>
        <zip>20138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Istituto Auxologico Italiano</name>
      <address>
        <city>Milano</city>
        <zip>20149</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Grande Ospedale Metropolitano Niguarda</name>
      <address>
        <city>Milano</city>
        <zip>20162</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Padua</name>
      <address>
        <city>Padua</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria di Parma</name>
      <address>
        <city>Parma</city>
        <zip>43126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico San Matteo Pavia Fondazione IRCCS</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione G. Monasterio CNR, Regione Toscana</name>
      <address>
        <city>Pisa</city>
        <zip>56124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda UnitÃ  Sanitaria Locale di Rimini - Regione Emilia Romagna</name>
      <address>
        <city>Rimini</city>
        <zip>47924</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Casilino Polyclinic</name>
      <address>
        <city>Roma</city>
        <zip>00169</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vannini Hospital Rome</name>
      <address>
        <city>Roma</city>
        <zip>00177</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sapienza University of Rome</name>
      <address>
        <city>Rome</city>
        <zip>00185</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Humanitas Research Hospital, Hospital Care and Research Institution, IRCCS,</name>
      <address>
        <city>Rozzano</city>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Siena</name>
      <address>
        <city>Siena</city>
        <zip>53100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lausanne University Hospital-CHUV</name>
      <address>
        <city>Lausanne</city>
        <zip>CH-1015</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bristol Heart Institute</name>
      <address>
        <city>Bristol</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King's College London</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Heart Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Greece</country>
    <country>Italy</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 21, 2017</study_first_submitted>
  <study_first_submitted_qc>November 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2017</study_first_posted>
  <last_update_submitted>November 21, 2017</last_update_submitted>
  <last_update_submitted_qc>November 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Centro Cardiologico Monzino</investigator_affiliation>
    <investigator_full_name>GIANLUCA PONTONE</investigator_full_name>
    <investigator_title>Director of MR Unit &amp; Deputy Director of Cardiovascular CT Unit</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Ventricular Dysfunction, Left</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

